No patent linkage

Bayer’s attempt to pre-empt Cipla’s cancer drug fails

The NATCO CL fallout

The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market

Monsanto's troublesome trait

Bayer is battling seed companies and farmers in several countries over royalty on Monsanto's GM seeds

Germany to phase out glyphosate by 2023

The country took this step to protect insect populations that play a pivotal role in ecosystems and pollination of food crops

Second guilty verdict against Monsanto in the US

Federal jury finds that Monsanto’s Roundup herbicide caused a man’s cancer

The end of meat and GMOs or the end of us: Part 1

The first in a three-part series series on effects of GMOs and the meat industry on our environment

SC rejects Bayer's appeal against compulsory licence for Nexavar

Indian pharma company, NATCO, can continue manufacturing generic version of liver and kidney cancer drug

Bayer to phase out toxic pesticides

Environmentalists say withdrawal because of economic viability

German company penalised for ‘Bhopal sister’ plant accident in US

A fatal explosion in the pesticide manufacturer’s plant in 2008 had led the US environment agency to draw a parallel with Bhopal gas …

Buzz of distress

Thousands of bees are dying in France due to Bayer pesticide

Long wait for justice for pregnancy test drug victims

Victims of hormonal drug, Primodos, in UK have been seeking justice for over 40 years now

A victory and a retreat on CLs

Supreme Court upholds India's first compulsory licence but government baulks at giving the second

Activists demand compulsory licence for another life-saving cancer drug

Appellate board's order upholding Natco's CL for sorafenib tosylate may pave way for manufacture of generic version of other patented drugs

A patent triumph of public interest

New flexibilities make public interest safeguards integral to drug patent rights

Even Japan not equipped to protect biosafety, says anti-GM group

Consumers' Union of Japan says its government has been unable to deal with the health and livelihood problems arising from imported GM canola

Rajasthan scraps seed pacts

ICAR tells Rajasthan to wait for guidelines on benefit sharing, biosafety

A pre-emptive strike against Monsanto

American organic farmers are trying to ensure the biotech giant cannot sue them

International people's tribunal indicts Monsanto, Dow Chemical and others for pesticide deaths, injuries

Jury headed by Upendra Baxi takes up Bhopal gas leak disaster and endosulfan deaths in Kerala, too

Big pharma’s dirty tricks

Drug giants from GSK, Abbott and Pfizer to Bayer have been fined for serious malpractices. They should be under close watch in India

Will appellate body uphold grant of compulsory licence to cancer drug?

Hearing on Bayer's appeal against manufacture of generic version of Nexavar to conclude this week

Indian company gets licence to manufacture and sell patented cancer drug

This is the first-ever compulsory licence given to a generic drug company

'Bt cotton has improved farmers' lives'

At the same time genetically modified cotton has increased fertilizer and water usage, resulting in high input costs, says study funded by farmers'…

GM crop field trials: anti-GM activists protest outside Moily's office

Moily’s approval will now allow event selection trials of rice, castor, cotton and a few other genetically modified crops ÒÇÇ

Rogue GM crops wreak havoc

Monsanto’s unauthorised GM wheat in the US has spooked the world, but contamination is widespread